Open AccessPercutaneous approach to treatment of coronary disease in a patient with uremic cardiomyopathy
Author(s) -
Giovanna Petrillo,
Plinio Cirillo,
Maria Prastaro,
Greta Luana D’Ascoli,
Federico Piscione
Publication year - 2011
Publication title -
world journal of cardiology
Language(s) - English
Resource type - Journals
ISSN - 1949-8462
DOI - 10.4330/wjc.v3.i4.117
Subject(s) - medicine , cardiology , coronary artery disease , dialysis , revascularization , hemodialysis , ischemic cardiomyopathy , angioplasty , cardiomyopathy , percutaneous , heart failure , end stage renal disease , disease , myocardial infarction , ejection fraction
Uremic cardiomyopathy is chronic ischemic left ventricular dysfunction characterized by heart failure, myocardial ischemia, hypotension in dialysis and arrhythmia. This nosologic entity represents a leading cause of morbidity and mortality among patients with end-stage renal disease receiving long-term hemodialysis. It is intuitive that revascularization in the presence of coronary artery disease in these patients represents an effective option for improving their prognosis. Although the surgical option seems to be followed by the best clinical outcome, some patients refuse this option and others are not good candidates for surgery. The present report describes the case of a patient affected by uremic cardiomyopathy and severe coronary artery disease in whom revascularization with percutaneous coronary angioplasty was followed by a significant improvement in quality of life.